Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$22.72 - $31.49 $227,200 - $314,900
10,000 Added 14.29%
80,000 $1.94 Million
Q2 2023

Aug 14, 2023

SELL
$25.3 - $39.67 $1.29 Million - $2.03 Million
-51,080 Reduced 42.19%
70,000 $1.94 Million
Q1 2023

May 15, 2023

SELL
$30.21 - $48.1 $398,772 - $634,920
-13,200 Reduced 9.83%
121,080 $4.03 Million
Q4 2022

Feb 14, 2023

SELL
$22.28 - $38.71 $160,416 - $278,712
-7,200 Reduced 5.09%
134,280 $4.12 Million
Q3 2022

Nov 14, 2022

BUY
$34.2 - $51.69 $365,940 - $553,083
10,700 Added 8.18%
141,480 $4.84 Million
Q2 2022

Aug 15, 2022

BUY
$23.14 - $49.68 $305,448 - $655,776
13,200 Added 11.23%
130,780 $4.54 Million
Q1 2022

May 16, 2022

SELL
$27.77 - $64.4 $1.36 Million - $3.16 Million
-49,100 Reduced 29.46%
117,580 $5.17 Million
Q4 2021

Feb 14, 2022

BUY
$54.9 - $105.21 $708,210 - $1.36 Million
12,900 Added 8.39%
166,680 $10.5 Million
Q3 2021

Nov 12, 2021

BUY
$105.0 - $178.37 $2.71 Million - $4.6 Million
25,800 Added 20.16%
153,780 $16.2 Million
Q2 2021

Aug 16, 2021

BUY
$125.11 - $180.0 $1.13 Million - $1.63 Million
9,030 Added 7.59%
127,980 $22.7 Million
Q1 2021

May 17, 2021

SELL
$126.27 - $191.71 $3.57 Million - $5.43 Million
-28,300 Reduced 19.22%
118,950 $15.9 Million
Q4 2020

Feb 16, 2021

BUY
$81.94 - $135.34 $2.31 Million - $3.81 Million
28,150 Added 23.64%
147,250 $19.9 Million
Q3 2020

Nov 16, 2020

BUY
$73.3 - $89.48 $3.21 Million - $3.91 Million
43,751 Added 58.06%
119,100 $9.91 Million
Q2 2020

Aug 14, 2020

BUY
$48.82 - $82.53 $597,996 - $1.01 Million
12,249 Added 19.41%
75,349 $6.19 Million
Q1 2020

May 14, 2020

BUY
$39.1 - $62.9 $2.47 Million - $3.97 Million
63,100 New
63,100 $3.25 Million
Q4 2019

Feb 14, 2020

SELL
$29.79 - $43.06 $521,325 - $753,550
-17,500 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$30.47 - $37.65 $18,282 - $22,590
600 Added 3.55%
17,500 $566,000
Q2 2019

Aug 15, 2019

BUY
$25.73 - $35.79 $434,837 - $604,851
16,900 New
16,900 $589,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $2.59B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.